A phase III randomised double-blind placebo-controlled parallel group efficacy and safety study of BI 10773 10 mg 25 mg administered orally once daily over 24 weeks in patients with type 2 diabetes with insufficient glycaemic control despite treatment with metformin alone or metformin in combination with a sulfonylurea
Klinisk prvning med kombinationsbehandling av kemoterapi och antikroppar fr behandling av patienter med gallgngscancer som inte kan opereras